The authors identified polymorphisms predicting individual HCC susceptibility in high-risk HBV and HCV patients, such as ERCC1, GSTP1, CYP17A1, XRCC3 and ABCB1. These findings could contribute to HCC surveillance and early detection (181). Here, GSTP1 is linked to hepatocellular carcinoma.